497 related articles for article (PubMed ID: 11850838)
1. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
Ala-aho R; Grénman R; Seth P; Kähäri VM
Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.
Ala-aho R; Ahonen M; George SJ; Heikkilä J; Grénman R; Kallajoki M; Kähäri VM
Oncogene; 2004 Jul; 23(30):5111-23. PubMed ID: 15094779
[TBL] [Abstract][Full Text] [Related]
3. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
4. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.
Johansson N; Airola K; Grénman R; Kariniemi AL; Saarialho-Kere U; Kähäri VM
Am J Pathol; 1997 Aug; 151(2):499-508. PubMed ID: 9250162
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas.
Moilanen M; Pirilä E; Grénman R; Sorsa T; Salo T
J Pathol; 2002 May; 197(1):72-81. PubMed ID: 12081207
[TBL] [Abstract][Full Text] [Related]
6. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
7. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim CH; Moon SK
Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
11. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
13. Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.
Lengyel E; Gum R; Juarez J; Clayman G; Seiki M; Sato H; Boyd D
Cancer Res; 1995 Feb; 55(4):963-7. PubMed ID: 7850814
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-gamma is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1.
Ala-aho R; Johansson N; Grénman R; Fusenig NE; López-Otín C; Kähäri VM
Oncogene; 2000 Jan; 19(2):248-57. PubMed ID: 10645003
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.
Sheikh MS; Li XS; Chen JC; Shao ZM; Ordonez JV; Fontana JA
Oncogene; 1994 Dec; 9(12):3407-15. PubMed ID: 7970699
[TBL] [Abstract][Full Text] [Related]
16. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
17. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
18. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
[TBL] [Abstract][Full Text] [Related]
19. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
[TBL] [Abstract][Full Text] [Related]
20. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]